Life Brand Acne Treatment Stick Recalled for Failed Assay
Oxygen Development LLC is recalling Life Brand Clear Action Acne Treatment Concealer Sticks because the salicylic acid content failed stability testing.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which is defined as unlikely to cause adverse health consequences. The issue is a failed assay (potency) rather than a contamination or acute safety hazard.
Plain-English summary
Oxygen Development LLC is recalling 12,216 units of Life Brand Clear Action Acne Treatment Concealer Stick (Salicylic acid), 1.9g. The product is identified by Lot # 060E and UPC 057800062653. It was imported for Shoppers Drug Mart Pharmaprix in Toronto, Canada.
The recall was initiated because the product is a superpotent drug that failed assay testing throughout the stick after six months of stability. This indicates the product did not meet the required potency standards over time.
Consumers who have purchased this specific lot should stop using the product and contact the retailer or manufacturer for instructions on return or disposal.
The recalled product
- Product
- Life Brand Clear Action Acne Treatment Concealer Stick (Salicylic acid), 1.9g, Imported for: Shoppers Drug Mart Pharmaprix Toronto, M2J4W8, UPC 057800062653
- Manufacturer
- Oxygen Development Llc
- Category
- Drug — Topical OTC
- Hazard
- Affected units
- 12,216
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 060E
Distribution
Distribution scope not specified by the agency.
Related recalls
Other drug recalls
- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- LowAcne Treatment Pads Recalled for Subpotent Salicylic Acid Levels
FDA (Drugs) · 2018-08-22
- HighSkin Script blemish spot treatment recalled for failing stability specifications
FDA (Drugs) · 2026-04-22
- LowValeant Recalls AcneFree Toner Pads Due to Low Salicylic Acid Content
FDA (Drugs) · 2012-11-14
- ModerateClearasil Rapid Rescue Deep Treatment Pads Recalled for Label Error
FDA (Drugs) · 2023-10-04
- SevereCeraVe Healing Lip Balm Recalled for Staphylococcus Aureus Contamination
FDA (Drugs) · 2018-10-24
- CriticalFDA Recalls Dr. King's SafeCare Rx Acne Clear Due to Microbial Contamination
FDA (Drugs) · 2019-03-20